Table 2. Patient characteristics.
| Overall (n=308) | Ischaemic T-CFC (n=88) | Normal T-CFC (n=220) | p-value | |
| Age, years | 69.0 (61.0-74.0) | 72.5 (61.8-75.0) | 68.0 (61.0-74.0) | 0.078 |
| Male | 160 (79.6) | 71 (80.7) | 175 (79.5) | 0.946 |
| Hypertension | 212 (68.6) | 65 (73.9) | 147 (66.8) | 0.285 |
| Dyslipidaemia | 194 (62.8) | 57 (64.8) | 137 (62.3) | 0.780 |
| Diabetes mellitus | 133 (43.0) | 49 (55.7) | 84 (38.2) | <0.001 |
| Current smoker | 77 (24.9) | 28 (31.8) | 49 (22.3) | 0.109 |
| Prior PCI | 77 (24.9) | 17 (19.3) | 60 (27.3) | 0.190 |
| Prior MI | 72 (23.3) | 17 (19.3) | 55 (25.0) | 0.360 |
| LDL cholesterol, mg/dl | 94.0 (76.0-111.0) | 91.0 (69.0-108.8) | 94.5 (78.3-112.0) | 0.186 |
| eGFR, mL/min/1.73 m² | 69.2 (57.4-83.4) | 65.9 (55.5-77.5) | 71.5 (58.1-84.2) | 0.134 |
| Ejection fraction, % | 63.0 (57.0-69.0) | 62.0 (56.0-68.0) | 63.0 (58.0-69.0) | 0.402 |
| Medication | ||||
| Statin | 208 (67.5) | 63 (71.6) | 145 (65.9) | 0.414 |
| ACE-I/ARB | 200 (64.7) | 59 (67.0) | 141 (64.1) | 0.720 |
| ß-blocker | 143 (46.3) | 42 (47.7) | 101 (45.9) | 0.871 |
| Data are presented as n (%), mean SD, or median (interquartile range). ACE-I: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; eGFR: estimated glomerular filtration rate; LDL: low-density lipoprotein; MI: myocardial infarction; PCI: percutaneous coronary intervention; T-CFC: thermodilution-derived coronary flow capacity | ||||